Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 69 citing articles:

Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)
Chaima Mouffouk, Soumia Mouffouk, Sara Mouffouk, et al.
European Journal of Pharmacology (2020) Vol. 891, pp. 173759-173759
Open Access | Times Cited: 154
Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds
Io Antonopoulou, Eleftheria Sapountzaki, Ulrika Rova, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 1306-1344
Open Access | Times Cited: 70
A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery
Aekkhaluck Intharuksa, Warunya Arunotayanun, Wipawadee Yooin, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4479-4479
Open Access | Times Cited: 66
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives
Hazim O. Khalifa, Yousef Al Ramahi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 739-739
Open Access | Times Cited: 12
Green-synthesized silver nanoparticles from Centella asiatica and Ayapana triplinervis: A novel approach to treating wound infections and reducing antimicrobial resistance
Jayasree Anandan, Rajeshkumar Shanmugam, Naiyf S. Alharbi, et al.
South African Journal of Botany (2025) Vol. 177, pp. 617-629
Closed Access | Times Cited: 1
An insight into the potent medicinal plant Phyllanthus amarus Schum. and Thonn.
Aparupa Bose Mazumdar Ghosh, Anindita Banerjee, Sharmila Chattopadhyay
The Nucleus (2022) Vol. 65, Iss. 3, pp. 437-472
Open Access | Times Cited: 36
Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize
Majambu Mbikay, Michel Chrètien
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30
Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic
Wan‐Yi Ho, Zi-han Shen, Yijing Chen, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30080-e30080
Open Access | Times Cited: 6
Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19
Rajeshwari Singh, Sumeet Goel, Pascale Bourgeade, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 40, pp. 55925-55951
Open Access | Times Cited: 36
Molecular Docking and In-Silico Analysis of Natural Biomolecules against Dengue, Ebola, Zika, SARS-CoV-2 Variants of Concern and Monkeypox Virus
Mackingsley Kushan Dassanayake, Teng-Jin Khoo, Chien Hwa Chong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11131-11131
Open Access | Times Cited: 24
Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2
Annie Roy, Mcw Chan, Logan Banadyga, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Phyllanthus Lignans: A Review of Biological Activity and Elicitation
Winda Nawfetrias, Lukita Devy, Rizkita Rachmi Esyanti, et al.
Horticulturae (2024) Vol. 10, Iss. 2, pp. 195-195
Open Access | Times Cited: 5
In silicoidentification of novel benzophenone–coumarin derivatives as SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibitors
Shashank M. Patil, Reshma Mary Martiz, Ramith Ramu, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 23, pp. 13032-13048
Closed Access | Times Cited: 32
Therapeutic Potential of Glycosyl Flavonoids as Anti-Coronaviral Agents
Patrícia I. C. Godinho, Raquel G. Soengas, Vera L. M. Silva
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 546-546
Open Access | Times Cited: 29
Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy
Mahdi Vajdi, Arash Karimi, Shirin Hassanizadeh, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 2, pp. 307-327
Closed Access | Times Cited: 4
Utilization of diamondback puffer (Lagocephalus guentheri) biomass for the production of bioactive oligopeptides and their inflammation suppressing effects in vitro
Akshad Balde, Poulomi Ghosh, Parthasarathi Aishwarya, et al.
Biocatalysis and Agricultural Biotechnology (2024) Vol. 58, pp. 103155-103155
Closed Access | Times Cited: 4
Review of nutritional component, phytochemistry and applications of Phyllanthus amarus
Victoria Adeola Falade, Sunday Olusegun Oladoye, E.T. Ayodele, et al.
Phytochemistry Reviews (2025)
Closed Access
Interaction of Bioactive Compounds of Moringa oleifera Leaves with SARS-CoV-2 Proteins to Combat COVID-19 Pathogenesis: a Phytochemical and In Silico Analysis
Sahabjada Siddiqui, Shivbrat Upadhyay, Rumana Ahmad, et al.
Applied Biochemistry and Biotechnology (2022) Vol. 194, Iss. 12, pp. 5918-5944
Open Access | Times Cited: 17
Integrated network pharmacology and pharmacological investigations to discover the active compounds of Toona sinensis pericarps against diabetic nephropathy
Huiting Li, Rongshen Wang, Ying Chen, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118441-118441
Closed Access | Times Cited: 3
Establishment of in-house assay for screening of anti-SARS-CoV-2 protein inhibitors
Merna H. Emam, M Mahmoud, Nadia El-Guendy, et al.
AMB Express (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Bioactive compound identification and in vitro evaluation of antidiabetic and cytotoxic potential of Garcinia atroviridis fruit extract
Muhammad Shahid, Shazrul Fazry, Ahmad Azfaralariff, et al.
Food Bioscience (2022) Vol. 51, pp. 102285-102285
Closed Access | Times Cited: 15
SARS-CoV 2 spike protein S1 subunit as an ideal target for stable vaccines: A bioinformatic study
Nagesha Somakalapalli Narasimhappa, Ramesh B.N., C. Pradeep, et al.
Materials Today Proceedings (2021) Vol. 49, pp. 904-912
Open Access | Times Cited: 20
In silico molecular docking of SARS-CoV-2 surface proteins with microbial non-ribosomal peptides: identification of potential drugs
Poonam Bansal, Raman Kumar, Jasbir Singh, et al.
Journal of Proteins and Proteomics (2021) Vol. 12, Iss. 3, pp. 177-184
Open Access | Times Cited: 20
Evaluating In Silico the Potential Health and Environmental Benefits of Houseplant Volatile Organic Compounds for an Emerging ‘Indoor Forest Bathing’ Approach
Valentina Roviello, Pasqualina Liana Scognamiglio, Ugo Caruso, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 19, Iss. 1, pp. 273-273
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top